- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有265家主力机构披露2026-06-30报告期持股数据，持仓量总计2.18亿股，占流通A股13.85%
- 波段诊断：
-
技术面诊股
诊断结果：6.2技术面打败了77%的股票
技术面评分前10的股票
近期的平均成本为13.36元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为13.36元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"13.36","date":1789632695,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2026.09.18","stock":"1.84","trade":"2.61","ind":"1.72"},{"date":"2026.09.17","stock":"0.77","trade":"1.50","ind":"-0.33"},{"date":"2026.09.16","stock":"-0.31","trade":"0.82","ind":"1.26"},{"date":"2026.09.15","stock":"-2.84","trade":"-1.62","ind":"-0.72"},{"date":"2026.09.14","stock":"2.29","trade":"2.96","ind":"-0.64"},{"date":"2026.09.11","stock":"0.69","trade":"-2.86","ind":"-1.08"},{"date":"2026.09.10","stock":"-3.35","trade":"-2.43","ind":"-0.77"},{"date":"2026.09.09","stock":"0.07","trade":"-1.46","ind":"0.15"},{"date":"2026.09.08","stock":"2.91","trade":"1.93","ind":"-0.52"},{"date":"2026.09.07","stock":"0.62","trade":"0.09","ind":"1.91"},{"date":"2026.09.04","stock":"-1.67","trade":"-0.93","ind":"-0.79"},{"date":"2026.09.03","stock":"0.08","trade":"0.47","ind":"0.10"},{"date":"2026.09.02","stock":"-3.16","trade":"-1.26","ind":"-1.88"},{"date":"2026.09.01","stock":"0.22","trade":"0.61","ind":"-1.02"},{"date":"2026.08.31","stock":"-4.83","trade":"-2.01","ind":"0.44"},{"date":"2026.08.28","stock":"-8.34","trade":"-2.41","ind":"-0.68"},{"date":"2026.08.27","stock":"2.10","trade":"0.32","ind":"1.50"},{"date":"2026.08.26","stock":"5.83","trade":"0.94","ind":"0.69"},{"date":"2026.08.25","stock":"-3.22","trade":"2.08","ind":"-0.35"},{"date":"2026.08.24","stock":"-7.45","trade":"-4.47","ind":"-2.13"},{"date":"2026.08.21","stock":"6.48","trade":"-3.50","ind":"0.87"}]
沃森生物,深证成指,生物制品指数
压力支撑
该股压力位为13.28元，支撑位为13.08元。
[{"text":"\u538b\u529b\u4f4d","value":"13.28","date":1789660800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.08","date":1789660800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.4资金面打败了13%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体无进出。
更新时间：09月18日 20:30
| 机构今日流向(万元) | -376.21 | 机构5日流向(万元) | -806.93 |
| 机构10日流向(万元) | -6532.10 | 机构20日流向(万元) | -24333.24 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少4616.26万股，其中基金净减仓38家，主力数没有增加，请投资者中长期谨慎为宜。
截止2026-06-30，共265家主力机构（基金262家，一般法人2家，社保基金1家），持仓量总计21836.47万股，占流通A股13.85%
其中，基金持仓与2025-12-31相比：
增仓：67家 ，增持 2778.21万股
减仓：105家 ，减持 3207.08万股
新出现在主力名单中：83家 ，持有2210.43万股
从主力名单中消失：83家 ，原持有6397.82万股
其中，基金持仓与2025-12-31相比：
增仓：67家 ，增持 2778.21万股
减仓：105家 ，减持 3207.08万股
新出现在主力名单中：83家 ，持有2210.43万股
从主力名单中消失：83家 ，原持有6397.82万股
消息面诊股
诊断结果：5.5消息面打败了26%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业周报|生物制品指数涨6.35%, 跑赢上证指数
2026-09-18 - 沃森生物：9月17日获融资买入7641.76万元
2026-09-18 - 沃森生物：公司本次发行方案经审慎论证，有利于公司长
2026-09-17 - 智翔金泰应付账款周转天数超千日 拖欠上游款项已成常
2026-09-17 - 沃森生物：9月16日获融资买入6601.75万元
2026-09-17 - 沃森生物：9月15日获融资买入6644.27万元
2026-09-16 - 我国首个自主原研mRNA疫苗正式获批上市
2026-09-15 - 沃森生物与水木未来达成战略合作，共建疫苗领域AI结
2026-09-15 - 沃森生物：9月14日获融资买入1.01亿元
2026-09-15 - 沃森生物：公司九价HPV疫苗目前处于III期临床研
2026-09-15
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-20 |
| 一般消息 | 高管变动 | 调整 | 2026-08-17 |
| 一般消息 | 高管变动 | 连续担任公司独立董事的时间即将满6... | 2026-08-12 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-04 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-04-22 |
| 利好 | 分红转增 | 10派1.25元(含税) | 2026-03-28 |
| 一般消息 | 募资投向 | 2026-03-28 | |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-20 |
| 利好 | 业绩预告 | 业绩预增 | 2026-01-29 |
| 一般消息 | 高管变动 | 不再担任 | 2026-01-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-20 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-20 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-19 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-12-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：6.8行业面打败了93%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.09.18","price":"1.72","value":"2.61"},{"date":"2026.09.17","price":"-0.33","value":"1.50"},{"date":"2026.09.16","price":"1.26","value":"0.82"},{"date":"2026.09.15","price":"-0.72","value":"-1.62"},{"date":"2026.09.14","price":"-0.64","value":"2.96"},{"date":"2026.09.11","price":"-1.08","value":"-2.86"},{"date":"2026.09.10","price":"-0.77","value":"-2.43"},{"date":"2026.09.09","price":"0.15","value":"-1.46"},{"date":"2026.09.08","price":"-0.52","value":"1.93"},{"date":"2026.09.07","price":"1.91","value":"0.09"},{"date":"2026.09.04","price":"-0.79","value":"-0.93"},{"date":"2026.09.03","price":"0.10","value":"0.47"},{"date":"2026.09.02","price":"-1.88","value":"-1.26"},{"date":"2026.09.01","price":"-1.02","value":"0.61"},{"date":"2026.08.31","price":"0.44","value":"-2.01"},{"date":"2026.08.28","price":"-0.68","value":"-2.41"},{"date":"2026.08.27","price":"1.50","value":"0.32"},{"date":"2026.08.26","price":"0.69","value":"0.94"},{"date":"2026.08.25","price":"-0.35","value":"2.08"},{"date":"2026.08.24","price":"-2.13","value":"-4.47"},{"date":"2026.08.21","price":"0.87","value":"-3.50"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 近岸蛋白 | 22.27% | 54.73% | 4.8分 |
| 2 | 百普赛斯 | 10.68% | 39.11% | 6.1分 |
| 3 | 金迪克 | 10.47% | 6.40% | 5.9分 |
| 4 | 赛伦生物 | 6.43% | 6.75% | 5.8分 |
| 5 | 华兰疫苗 | 2.97% | 6.74% | 6.0分 |
| 6 | 上海莱士 | 2.28% | 0.82% | 5.2分 |
| 8 | 禾元生物 | 1.29% | 6.58% | 6.4分 |
| 10 | 四环生物 | 0.53% | 3.24% | 5.1分 |
| 12 | 卫光生物 | -1.52% | 1.22% | 4.5分 |
| 14 | 华兰生物 | -1.82% | 1.02% | 5.2分 |
| 16 | 成大生物 | -2.61% | 1.46% | 4.4分 |
| 18 | 通化东宝 | -3.21% | 1.29% | 5.3分 |
| 20 | 义翘神州 | -3.98% | 23.25% | 6.4分 |
| 22 | 优宁维 | -4.37% | 6.70% | 5.9分 |
| 24 | 博雅生物 | -5.14% | 1.91% | 4.9分 |
| 26 | 东宝生物 | -6.83% | -0.41% | 5.1分 |
| 28 | 派林生物 | -7.06% | -1.50% | 4.6分 |
| 30 | 昊帆生物 | -7.63% | 9.81% | 6.5分 |
| 32 | 智飞生物 | -8.27% | 1.11% | 4.6分 |
| 34 | 康华生物 | -8.76% | 5.94% | 5.5分 |
| 36 | 长春高新 | -10.06% | 0.06% | 4.7分 |
| 38 | *ST未名 | -10.36% | -2.81% | 4.7分 |
| 40 | 君实生物 | -10.93% | 7.03% | 5.5分 |
| 42 | 泰诺麦博 | -11.19% | 12.88% | 5.0分 |
| 44 | 万泽股份 | -11.69% | -0.62% | 4.4分 |
| 46 | 康希诺 | -11.99% | 7.50% | 4.4分 |
| 48 | 迈威生物 | -14.60% | 10.64% | 5.0分 |
| 50 | 赛升药业 | -15.14% | 2.31% | 4.4分 |
| 52 | 百奥泰 | -16.95% | 5.91% | 4.8分 |
| 54 | 我武生物 | -21.10% | 2.48% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 28/73 ， 28/73。
[{"date":"2026-06-30","value":"0.69","vol":"-8.07"},{"date":"2026-03-31","value":"1.38","vol":"-6.34"},{"date":"2025-12-31","value":"1.97","vol":"-12.02"},{"date":"2025-09-30","value":"1.71","vol":"-9.89"},{"date":"2025-06-30","value":"0.46","vol":"-3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.69 | 1.38 | 1.97 | 1.71 | 0.46 |
| 行业(%) | -8.07 | -6.34 | -12.02 | -9.89 | -3.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"68.79","vol":"55.74"},{"date":"2026-03-31","value":"68.47","vol":"60.27"},{"date":"2025-12-31","value":"74.56","vol":"65.27"},{"date":"2025-09-30","value":"71.69","vol":"66.41"},{"date":"2025-06-30","value":"70.28","vol":"66.14"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
68.79 | 68.47 | 74.56 | 71.69 | 70.28 |
| 行业(%) | 55.74 | 60.27 | 65.27 | 66.41 | 66.14 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，两项指标的行业排名分别为 47/73 ， 18/73。
[{"date":"2026-06-30","value":"-27.72","vol":"31.09"},{"date":"2026-03-31","value":"-3.98","vol":"291.45"},{"date":"2025-12-31","value":"-14.29","vol":"39.10"},{"date":"2025-09-30","value":"-19.73","vol":"44.93"},{"date":"2025-06-30","value":"-19.47","vol":"6771.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-27.72 | -3.98 | -14.29 | -19.73 | -19.47 |
| 行业(%) | 31.09 | 291.45 | 39.10 | 44.93 | 6771.91 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"25.56","vol":"18.81"},{"date":"2026-03-31","value":"4082.41","vol":"71.92"},{"date":"2025-12-31","value":"25.03","vol":"36.03"},{"date":"2025-09-30","value":"-36.24","vol":"44.79"},{"date":"2025-06-30","value":"-74.69","vol":"5.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
25.56 | 4082.41 | 25.03 | -36.24 | -74.69 |
| 行业(%) | 18.81 | 71.92 | 36.03 | 44.79 | 5.12 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，两项指标的行业排名分别为 43/73 ， 27/73。
[{"date":"2026-06-30","value":"0.07","vol":"0.14"},{"date":"2026-03-31","value":"0.04","vol":"0.06"},{"date":"2025-12-31","value":"0.18","vol":"0.30"},{"date":"2025-09-30","value":"0.12","vol":"0.21"},{"date":"2025-06-30","value":"0.08","vol":"0.13"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.04 | 0.18 | 0.12 | 0.08 |
| 行业(次) | 0.14 | 0.06 | 0.30 | 0.21 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.44","vol":"0.63"},{"date":"2026-03-31","value":"0.25","vol":"0.28"},{"date":"2025-12-31","value":"0.93","vol":"1.26"},{"date":"2025-09-30","value":"0.75","vol":"0.88"},{"date":"2025-06-30","value":"0.50","vol":"0.54"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.44 | 0.25 | 0.93 | 0.75 | 0.50 |
| 行业(次) | 0.63 | 0.28 | 1.26 | 0.88 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 5/73 ， 24/73。
[{"date":"2026-06-30","value":"49.74","vol":"-1291.20"},{"date":"2026-03-31","value":"-4.56","vol":"-144.81"},{"date":"2025-12-31","value":"58.80","vol":"12.60"},{"date":"2025-09-30","value":"-6.55","vol":"0.21"},{"date":"2025-06-30","value":"40.22","vol":"-1377.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 49.74 | -4.56 | 58.80 | -6.55 | 40.22 |
| 行业 | -1291.20 | -144.81 | 12.60 | 0.21 | -1377.57 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.89","vol":"1.53"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.24","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.67","vol":"1.53"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.89 | - | 1.24 | - | 0.67 |
| 行业 | 1.53 | 0.00 | 1.73 | 0.00 | 1.53 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 2/73 ， 13/73。
[{"date":"2026-06-30","value":"2.07","vol":"5.55"},{"date":"2026-03-31","value":"2.16","vol":"6.58"},{"date":"2025-12-31","value":"2.35","vol":"5.74"},{"date":"2025-09-30","value":"3.52","vol":"5.95"},{"date":"2025-06-30","value":"2.82","vol":"6.47"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.07 | 2.16 | 2.35 | 3.52 | 2.82 |
| 行业 | 5.55 | 6.58 | 5.74 | 5.95 | 6.47 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.47","vol":"4.13"},{"date":"2026-03-31","value":"1.67","vol":"5.09"},{"date":"2025-12-31","value":"1.85","vol":"4.39"},{"date":"2025-09-30","value":"2.41","vol":"4.79"},{"date":"2025-06-30","value":"2.09","vol":"5.16"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.47 | 1.67 | 1.85 | 2.41 | 2.09 |
| 行业 | 4.13 | 5.09 | 4.39 | 4.79 | 5.16 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 17/73 ， 21/73。
[{"date":"2026-06-30","value":"30.18","vol":"30.05"},{"date":"2026-03-31","value":"29.79","vol":"29.49"},{"date":"2025-12-31","value":"20.99","vol":"29.33"},{"date":"2025-09-30","value":"17.42","vol":"27.48"},{"date":"2025-06-30","value":"23.11","vol":"27.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
30.18 | 29.79 | 20.99 | 17.42 | 23.11 |
| 行业(%) | 30.05 | 29.49 | 29.33 | 27.48 | 27.37 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.45","vol":"1.38"},{"date":"2026-03-31","value":"0.45","vol":"2.52"},{"date":"2025-12-31","value":"0.29","vol":"1.42"},{"date":"2025-09-30","value":"0.24","vol":"0.57"},{"date":"2025-06-30","value":"0.34","vol":"1.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.45 | 0.45 | 0.29 | 0.24 | 0.34 |
| 行业(%) | 1.38 | 2.52 | 1.42 | 0.57 | 1.24 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"7.29","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.19","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.78","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]